IBA also has a long-term strategic collaboration with Royal Philips (NYSE: PHG, AEX: PHIA). By combining their respective expertise in image guidance and therapy, Philips and IBA continue to co-innovate diagnostic and therapeutic oncology solutions designed to enable more effective and personalized cancer care. Our combined portfolio focuses on fast and easy workflow, from imaging through treatment, while maximizing patient comfort and providing a soothing treatment experience.
IBA and RaySearch Laboratories ("RaySearch") will present their online adaptive proton therapy workflow where daily optimized plans are created for each individual patient based on cone beam CT images to preserve the original treatment intent. Both companies are demonstrating RaySearch RayCare®, the innovative new oncology information system (OIS) designed to support comprehensive cancer care, and the RayStation workflow and treatment planning system, as well as IBA's AdaPT Insight imaging platform and AdaPT Deliver treatment delivery. The solution automatically suggests to the care team an adapted treatment plan based on the most up-to-date patient's anatomy. This workflow offers more accurate treatment plans as well as faster plan adaptation to the benefit of patients. Demonstrations can be booked by visiting either RaySearch's or IBA's booth.
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Registration to the IBA proton therapy activities on the booth is available here.
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.
Back to HCB News
